What are the Different Types of Non-Hodgkin Lymphoma?

SOG_4567_13SMALL

Although lymphoma diagnoses are often categorized as either Hodgkin lymphoma or non-Hodgkin lymphoma, there are many subtypes of each disease, with more than 50 subtypes of non-Hodgkin lymphoma alone. Most forms of the more than 70,000 new cases of non-Hodgkin lymphoma diagnosed in the U.S. each year can be broken up into two main subtypes: B-cell lymphomas and T-cell lymphomas. The subtype is based on whether the cancer cells develop in the body’s B-cells or T-cells, which are two forms of white blood cells. The maturity of the B-cell or T-cell also dictates the type of lymphoma that develops. Read …

Continue reading

Mother and Son, Both Cancer Survivors, Share Their Story on Radio-Telethon

SAM_1237_150square

When Lisa Robert is interviewed at Fenway Park  for the WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance Foundation (Aug 19-20), her mind will no doubt drift back to 1976, when she was a 7-year-old leukemia patient at Dana-Farber and had the thrill of her life. She threw out the first pitch of the season at Fenway to Boston Red Sox catcher Carlton Fisk. Lisa won’t be the only member of her family reminiscing on air about pediatric cancer. Her son, Josh Robert, now 17, was treated at Dana-Farber in 2009 for Burkitt’s lymphoma. Two generations of Jimmy Fund Clinic …

Continue reading

Lymphoma Survivor Tackles Breast Cancer While Helping Fellow Patients

265801_1978035810615_1438390_o.jpgSMALL

By Catherine Goff When you’re 21, the last words you expect to hear are “you have cancer.” But, that was exactly the news I received in 1976 after a routine trip to my college infirmary landed me in Boston Children’s Hospital with Hodgkin lymphoma. Thanks to new treatments developed through clinical trials and a summer undergoing radiation therapy at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), I was deemed cancer-free. While I wanted to say, “I beat it,” I knew the five-year mark was a big milestone for Hodgkin lymphoma patients, and I was nervous until I reached that goal. How much …

Continue reading

Boston Mayor Marty Walsh ‘Proud to be a Cancer Survivor’

SOG_2120_14

Boston Mayor Marty Walsh recently gave the keynote address at Dana-Farber’s Living Proof: Celebrating Survivorship event. He shared his experience as a child being treated for Burkitt’s lymphoma at Dana-Farber and Boston Children’s Hospital. Below are some excerpts from his speech:  I was diagnosed with cancer at age 7. I went through treatment for almost four years. At 7-years old, I didn’t really know what was going on and how serious it was – and it was pretty serious. For many years I missed a lot of school. I missed most of my second and third grades. When I finally went into remission, …

Continue reading

A Tattoo and a Bulldog: How One Family Coped with Cancer

By Cindy Coyle My husband Bill was diagnosed with mantle cell lymphoma in January 2012. Needless to say it was a great shock to us and our three children, Billy, Sasha-Lee, and Jimmy. Looking back, I realize how two unlikely events guided us through his treatment and recovery: a tattoo and a bulldog.

Hodgkin Lymphoma: Five Things You Need to Know

Approximately 173,000 people in the United States are living with Hodgkin lymphoma, or are in remission. Less common than non-Hodgkin lymphoma, Hodgkin lymphoma (sometimes referred to as Hodgkin’s lymphoma) is a malignancy of B lymphocytes, an important cell in the immune system. This malignant B cell is known as the Reed-Sternberg cell. Arnold Freedman, MD, clinical director of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answers some questions about the disease:

Chat Live with a Dana-Farber Lymphoma Expert

Lymphoma: How do we treat it? Where are future therapies headed? On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page. LaCasce will discuss current treatment options as well as future therapies for lymphoma. If you have a question for Dr. LaCasce, email webchats@dfci.harvard.edu. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat. Bookmark the webchat video page and …

Continue reading

Clinical Trials and the Future of Lymphoma Treatment

Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials. “Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.